(Q41009890)

25 September 2017

1 reference

title

Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance (English)

1 reference

25 September 2017

1 reference

T Y Chan

1

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

Annals of Pharmacotherapy

25 September 2017

published in

1 reference

25 September 2017

volume

29

1 reference

25 September 2017

issue

12

1 reference

25 September 2017

page(s)

1274-1283

1 reference

Clinically significant drug interactions with the oral anticoagulants

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Warfarin: is it time to reduce target ranges again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Factors affecting warfarin requirements. A prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Interaction between Oral Anti-Coagulant Drugs and Non-Steroidal Anti-Inflammatory Agents: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Interactions of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Hematologic perturbations associated with salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Protein binding drug displacement interactions fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Non-steroidal anti-inflammatory drugs and peptic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Non-steroidal anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Interaction of ibuprofen and warfarin on primary haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Failure of Indomethacin and Warfarin to Interact in Normal Human Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Drug interactions with coumarin anticoagulants. 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Potentiation of warfarin by azapropazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Azapropazone and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Azapropazone and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Adverse interaction between warfarin and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Warfarin and topical salicylates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Letter: Drug enhancement of warfarin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

A warfarin-piroxicam drug interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Factors affecting the maintenance dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Pharmacokinetics and pharmacodynamics of warfarin at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Age as a determinant of sensitivity to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Risk factors for intracranial hemorrhage in outpatients taking warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

Adverse Reactions to Drugs as a Cause of Admissions to a General Teaching Hospital in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901214

10.1177/106002809502901214

21 January 2018

Identifiers

DOI

1 reference

release_dwgrsc7qn5ee5l3xx3eylykf3i

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dwgrsc7qn5ee5l3xx3eylykf3i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference